Oncology
From the Journals
Cannabis Overuse Linked to Increased Risk for Head and Neck Cancer
Researchers analyzed data of 116,000 individuals with cannabis-related disorder.
Latest News
PCP Visits Save Lives of Older Patients After Cancer Surgery
Patients with a primary care visit within 90 postoperative days had a significantly lower 90-day mortality rate.
From the Journals
Modest Gains Shown in Breast Cancer Immunotherapy Trials
Researchers evaluated 331 immunotherapy trials, enrolling nearly 50,000 patients with breast cancer.
From the Journals
Can Addressing Depression Reduce Chemo Toxicity in Older Adults?
Researchers evaluated whether greater reductions in grade 3 chemotherapy-related toxicities occurred with geriatric assessment-driven...
Latest News
Artera Launches AI Test for Decision-Making on Prostate Cancer Treatment Course
The test estimates how a patient’s cancer may progress and predicts the benefit of treatment for localized prostate.
News from the FDA/CDC
FDA Expands Dostarlimab-gxly Approval for Endometrial Cancer
‘This is the only immuno-oncology treatment regimen that has shown a statistically significant overall survival benefit for the full patient...
From the Journals
The Last 30 Days: How Oncologists’ Choices Affect End-of-Life Cancer Care
Researchers analyze data from more than 17,000 patients who died of cancer between 2012 and 2017.
From the Journals
Ancient Viruses in Our DNA Hold Clues to Cancer Treatment
Targeting remnants of a virus in our DNA could lead to more effective cancer treatment with fewer side effects.
Conference Coverage
Outcomes with CDK4/6 Inhibitors Vary in BC
A large Italian study found real-world differences in short-term outcomes among first line CDK4/6 inhibitors palbociclib, ribociclib and...
Feature
Breakthrough Blood Test for Colorectal Cancer Gets Green Light
The test’s approval could make it more likely that people get screened for and survive the disease.
From the Journals
Baseline Bone Pain Predicts Survival in Metastatic Hormone-Sensitive Prostate Cancer
Researchers conduct a post hoc secondary analysis to examine the relationship between bone pain and overall survival.